Optimizing TCR gene transfer

Clinical Immunology

Volumn 119, Issue 2, 2006, Pages 121-122

  Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645976843     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.01.006     Document Type: Note

References (18)

1. Yee C., Thompson J.A., Byrd D., Riddell S.R., Roche P., Celis E., and Greenberg P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16168-16173
2. Yee C., Thompson J.A., Byrd D., Riddell S.R., Roche P., Celis E., and Greenberg P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16168-16173
3. Rooney C.M., Smith C.A., Ng C.Y., Loftin S., Li C., Krance R.A., Brenner M.K., and Heslop H.E. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345 (1995) 9-13
4. Cooper L.J., Kalos M., Lewinsohn D.A., Riddell S.R., and Greenberg P.D. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J. Virol. 74 (2000) 8207-8212
5. Fujio K., Misaki Y., Setoguchi K., Morita S., Kawahata K., Kato I., Nosaka T., Yamamoto K., and Kitamura T. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex. J. Immunol. 165 (2000) 528-532
6. Heemskerk M.H., Hoogeboom M., de Paus R.A., Kester M.G., van der Hoorn M.A., Goulmy E., Willemze R., and Falkenburg J.H. Redirection of anti-leukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2 specific T cell receptor complexes expressing a conserved alpha joining region. Blood 102 (2003) 3530-3540
7. Heemskerk M.H., Hoogeboom M., Hagedoorn R., Kester M.G., Willemze R., and Falkenburg J.H. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer. J. Exp. Med. 199 (2004) 885-894
8. Kessels H.W., Wolkers M.C., van den Boom M.D., van der Valk M.A., and Schumacher T.N. Immunotherapy through TCR gene transfer. Nat. Immunol. 2 (2001) 957-961
9. Orentas R.J., Roskopf S.J., Nolan G.P., and Nishimura M.I. Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide. Clin. Immunol. 98 (2001) 220-228
10. Stanislawski T., Voss R.H., Lotz C., Sadovnikova E., Willemsen R.A., Kuball J., Ruppert T., Bolhuis R.L., Melief C.J., Huber C., Stauss H.J., and Theobald M. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. 2 (2001) 962-970
11. Labrecque N., Whitfield L.S., Obst R., Waltzinger C., Benoist C., and Mathis D. How much TCR does a T cell need?. Immunity 15 (2001) 71-82
12. Viola A., and Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273 (1996) 104-106
13. Schaft N., Willemsen R.A., De Vries J., Lankiewicz B., Essers B.W., Gratama J.W., Figdor C.G., Bolhuis R.L., Debets R., and Adema G.J. Peptide fine specificity of anti-Glycoprotein 100 CTL is preserved following transfer of engineered TCRalphabeta genes into primary human T lymphocytes. J. Immunol. 170 (2003) 2186-2194
14. Engels B., Cam H., Schuler T., Indraccolo S., Gladow M., Baum C., Blankenstein T., and Uckert W. Retroviral vectors for high-level transgene expression in T lymphocytes. Hum. Gene Ther. 14 (2003) 1155-1168
15. Schambach A., Wodrich H., Hildinger M., Bohne J., Krausslich H.G., and Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol. Ther. 2 (2000) 435-445
16. Scholten K.B., Kramer D., Kueter E.W., Graf M., Schoedl T., Meijer C.J., Schreurs M.W., and Hooijberg E. Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells. Clin. Immunol. 119 (2006) 135-145
17. Aarnoudse C.A., van den Doel P.B., Heemskerk B., and Schrier P.I. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1. Int. J. Cancer 82 (1999) 442-448
18. Wang R.F., Parkhurst M.R., Kawakami Y., Robbins P.F., and Rosenberg S.A. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183 (1996) 1131-1140